Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.76B
EV5.76B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Revenue
99.9
95.9
101.3
98.0
103.6
129.7
190.6
199.1
291.3
310.4
Revenue % Chg.
19.3%
-4.0%
5.6%
-3.3%
5.6%
25.3%
47.0%
4.5%
46.3%
6.6%
Cost of Revenue
73.3
65.7
63.7
60.6
64.7
77.2
109.2
111.5
182.3
235.8
Gross Profit
26.6
30.2
37.6
37.4
38.8
52.5
81.4
87.6
108.9
74.6
Gross Profit Margin
26.6%
31.5%
37.2%
38.1%
37.5%
40.5%
42.7%
44.0%
37.4%
24.0%
R&D Expenses
4.6
4.6
5.9
7.1
7.7
9.6
11.3
12.8
18.1
19.3
Selling, General, & Admin Expenses
3.4
4.0
4.3
5.8
5.4
8.2
9.2
11.9
11.0
20.3
Other Expenses
4.4
5.8
8.0
7.6
6.9
7.7
10.5
9.7
9.9
10.0
Operating Income
14.3
15.8
19.5
16.8
18.8
27.0
48.2
58.4
58.2
22.2
Operating Income Margin
14.3%
16.4%
19.2%
17.2%
18.2%
20.8%
25.3%
29.3%
20.0%
7.2%
Total Other Income/Expenses Net
-3.5
-4.1
-5.9
-2.6
-3.8
-9.7
-15.9
-14.2
-0.6
-31.7
Income Before Tax
10.8
11.6
13.6
14.2
15.1
17.3
32.3
44.2
57.6
-9.5
Income Before Tax Margin
10.8%
12.1%
13.4%
14.5%
14.6%
13.3%
17.0%
22.2%
19.8%
-3.1%
Income Tax Expense
1.6
1.9
2.9
3.1
3.2
3.4
5.7
7.3
9.6
0.9
Net Income
9.3
9.9
10.0
11.1
12.1
13.6
24.8
34.8
47.2
-10.5
Net Income Margin
9.3%
10.3%
9.9%
11.3%
11.7%
10.5%
13.0%
17.5%
16.2%
-3.4%
Weighted Avg. Shares Out
175.7
176.9
175.5
219.4
236.1
235.4
331.2
334.2
344.4
344.8
EPS
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
-0.0
EPS % Chg.
77.5%
5.6%
2.7%
-11.7%
1.5%
13.0%
28.2%
39.2%
32.4%
—
Weighted Avg. Shares Out Dil
175.7
176.9
175.5
219.4
236.1
235.4
331.2
334.2
340.8
344.8
EPS Diluted
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
-0.0
Interest Income
0.1
0.1
0.1
0.1
0.1
0.4
0.3
0.6
0.8
1.4
Interest Expense
4.0
4.7
5.4
3.6
5.0
9.5
12.0
13.4
10.8
13.5
EBIT
6.8
7.1
8.3
10.7
10.2
8.3
20.6
31.4
47.7
-21.6
EBIT Margin
6.8%
7.4%
8.2%
10.9%
9.8%
6.4%
10.8%
15.8%
16.4%
-7.0%
Depreciation & Amortization
6.3
7.4
8.4
9.5
10.5
12.3
15.9
18.4
35.0
23.4
EBITDA
13.2
14.5
16.7
20.2
20.7
20.6
36.4
49.8
82.7
1.8
EBITDA Margin
13.2%
15.1%
16.5%
20.7%
20.0%
15.9%
19.1%
25.0%
28.4%
0.6%